Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study
Evaluating of efficacy in first phase of long term study which was dealing with induction of remission on low disease activity in patients with moderately active rheumatoid arthritis in states of central and eastern Europe